Sponsor

Humanitas Research Hospital IRCCS, Rozzano-Milan

Clinical research sponsor

Published trials9

Recruiting shown3

Roles1

SourceClinicalTrials.gov

Clinical trials

9 shown

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimenNCT07061379 · collaborator · 2025-07-24

RECRUITING

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · collaborator · 2023-05-01

RECRUITING

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast CancerNCT05377047 · collaborator · 2022-09-19

RECRUITING

Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and AbemaciclibNCT07428018 · collaborator · 2026-04-30

NOT_YET_RECRUITING

Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)NCT06440629 · collaborator · 2024-08-20

ACTIVE_NOT_RECRUITING

OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF RegistryNCT06192524 · collaborator · 2022-07-18

UNKNOWN

Validation of the I-UDS Neuropsychological BatteryNCT05803122 · collaborator · 2022-07-15

COMPLETED

OMEGA, Local Ablative Therapy in Oligometastatic NSCLCNCT03827577 · collaborator · 2019-10-01

UNKNOWN

Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular FunctionNCT02509754 · collaborator · 2016-01-01

UNKNOWN

Sponsor roles

collaborator9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.